Why the study?
While short- and medium-term outcomes after CRT have been extensively reported, data on very long-term outcomes (10+ years) remain limited.
Does nonischemic cardiomyopathy compared to ischemic cardiomyopathy improve very long-term survival in patients undergoing CRT-D?
Does nonischemic cardiomyopathy compared to ischemic cardiomyopathy improve very long-term survival in patients undergoing CRT-D?
Over a very long-term follow-up of more than 10 years, patients with nonischemic cardiomyopathy have significantly higher survival post-CRT-D compared to those with ischemic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Etiology should not yet guide CRT-D decisions; extends observational survival data to >10 years in NICM versus ICM.
Gupta et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: